Loratadine

CAS 79794-75-5 13 current records 9 historicalSmall Molecule

Who holds supplier records for Loratadine? 13 organisations hold a current record for Loratadine: an active US FDA Type II Drug Master File or a CEP. A further 9 organisations have only historical (inactive) DMF filings. 11 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: India (10), Spain (2) and Belgium (1).

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records

Cite as: PharmaTek, “Loratadine: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/loratadine

Reading the evidence

  • 13 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • Most recorded organisations are in India

    10 of the 13 current records with a recorded country list India. Organisation country is not necessarily the manufacturing site.

  • 8 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

Current records (13)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Loratadine. Country is the organisation's recorded country, not necessarily the manufacturing site.

Need Loratadine sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Valid CEP holder entries (11)

Certificates of Suitability on the EDQM register for Loratadine, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 12 certificates in total, including withdrawn, expired, suspended and repeat certificates.

HolderCountryCertificateIssuedEU GMP at holder's address
MATRIX PHARMACORP PRIVATE LIMITED SangareddyIN
CEP 2007-171 - Rev 07
Loratadine
May 2026—
QUIMICA SINTETICA S.A. Alcala De HenaresES
CEP 2025-493 - Rev 00
Loratadine, Process II, Micronised
Jan 2026Inspected Apr 2025
Spain
VASUDHA PHARMA CHEM LIMITED HyderabadIN
CEP 2009-009 - Rev 04
Loratadine
Nov 2025—
ZYDUS LIFESCIENCES LIMITED VadodaraIN
CEP 2007-254 - Rev 04
Loratadine, Form I
Sept 2025—
MOREPEN LABORATORIES LIMITED BaddiIN
CEP 2007-348 - Rev 05
Loratadine, Milled, micronised
Sept 2024Inspected Mar 2026
Spain
TAGOOR LABORATORIES PRIVATE LIMITED VisakhapatnamIN
CEP 2023-059 - Rev 00
Loratadine
Jul 2024—
CADILA PHARMACEUTICALS LIMITED AnkleshwarIN
CEP 2007-284 - Rev 03
Loratadine
Jan 2024—
ARENE LIFE SCIENCES PRIVATE LIMITED RamachandrapuramIN
R0-CEP 2021-294 - Rev 00
Loratadine
Oct 2022—
SUN PHARMACEUTICAL INDUSTRIES LIMITED MumbaiIN
R1-CEP 2008-282 - Rev 02
Loratadine
Jun 2019—
ROLABO OUTSOURCING, S.L. ZaragozaES
R1-CEP 2007-283 - Rev 01
Loratadine
Mar 2017—
SCHERING-PLOUGH EUROPE BrusselsBE
R1-CEP 2007-218 - Rev 00
Loratadine, Micronised
Dec 2013—

The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.

Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.

Historical records (9)

Organisations whose Type II DMFs for Loratadine are no longer active. These show a past filing, not current supply.

Show all 9 historical records
  • India · Inactive DMF 20496 · filed Apr 2007
  • ZHEJIANG WEPON PHARMACEUTICAL CO LTD
    Inactive DMF 19740 · filed May 2006
  • SUZHOU WANQING PHARMACEUTICALS CO LTD
    Inactive DMF 18058 · filed Feb 2005
  • India · Inactive DMF 17810 · filed Nov 2004
  • MYLAN LABORATORIES LTD
    Inactive DMF 17287 · filed Apr 2004
  • India · Inactive DMF 16970 · filed Nov 2003
  • Spain · Inactive DMF 13842 · filed Nov 1998
  • Spain · Inactive DMF 13811 · filed Oct 1998
  • MSD INTERNATIONAL GMBH
    Inactive DMF 13032, 6626 · filed Jun 1998

Overview

Loratadine is a second-generation antihistamine drug used to treat allergic rhinitis and urticaria. It works by blocking the action of histamine, a substance in the body that causes allergic symptoms.

Chemical identity

IUPAC name
ethyl 4-(13-chloro-4-azatricyclo[9.4.0.03,8]pentadeca-1(11),3(8),4,6,12,14-hexaen-2-ylidene)piperidine-1-carboxylate
Canonical SMILES
CCOC(=O)N1CCC(=C2C3=C(CCC4=C2N=CC=C4)C=C(C=C3)Cl)CC1
InChIKey
JCCNYMKQOSZNPW-UHFFFAOYSA-N
Synonyms
Claritin API, loratadine, Claritin, Alavert, Clarityn, Clarityne, Lisino, Fristamin, Loracert, Loradex, Bonalerg, Claritine

Therapeutic areas

AllergyAntihistamine

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Loratadine?

13 organisations hold an active US FDA Type II Drug Master File or a CEP for Loratadine: MOREPEN LABORATORIES LTD (India), VASUDHA PHARMA CHEM LTD (India), Cadila Pharmaceuticals Limited (India), MATRIX PHARMACORP PRIVATE LTD (India), QUIMICA SINTETICA SA (Spain), ROLABO OUTSOURCING SL (Spain), Sun Pharmaceutical Industries Limited (India) and Zydus Lifesciences Limited (India), and 5 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Loratadine Drug Master Files are active?

MOREPEN LABORATORIES LTD (DMF 20669, 12650), VASUDHA PHARMA CHEM LTD (DMF 20367, 34822), Cadila Pharmaceuticals Limited (DMF 17582), MATRIX PHARMACORP PRIVATE LTD (DMF 20447), QUIMICA SINTETICA SA (DMF 9830, 11803), ROLABO OUTSOURCING SL (DMF 14155), Sun Pharmaceutical Industries Limited (DMF 15251) and Zydus Lifesciences Limited (DMF 18702) and 2 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

What do the historical Loratadine records mean?

9 organisations have only inactive Type II DMFs for Loratadine. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.

Does Loratadine have a European Certificate of Suitability?

Yes. 11 organisations hold a valid CEP for Loratadine on the EDQM register, including MATRIX PHARMACORP PRIVATE LIMITED Sangareddy (IN), QUIMICA SINTETICA S.A. Alcala De Henares (ES), VASUDHA PHARMA CHEM LIMITED Hyderabad (IN), ZYDUS LIFESCIENCES LIMITED Vadodara (IN), MOREPEN LABORATORIES LIMITED Baddi (IN) and TAGOOR LABORATORIES PRIVATE LIMITED Visakhapatnam (IN) and 5 more. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.

How do I qualify a Loratadine supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Loratadine?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.